166 related articles for article (PubMed ID: 10749590)
1. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
[TBL] [Abstract][Full Text] [Related]
2. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma.
Maeda K; Chung YS; Takatsuka S; Ogawa Y; Onoda N; Sawada T; Kato Y; Nitta A; Arimoto Y; Kondo Y
Br J Cancer; 1995 Aug; 72(2):319-23. PubMed ID: 7543771
[TBL] [Abstract][Full Text] [Related]
3. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.
Tenderenda M; Rutkowski P; Jesionek-Kupnicka D; Kubiak R
Pathol Oncol Res; 2001; 7(2):129-34. PubMed ID: 11458276
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
Kakeji Y; Maehara Y; Adachi Y; Baba H; Mori M; Furusawa M; Sugimachi K
Br J Cancer; 1994 Apr; 69(4):749-53. PubMed ID: 7908217
[TBL] [Abstract][Full Text] [Related]
6. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1.
Broll R; Mahlke C; Best R; Schimmelpenning H; Strik MW; Schiedeck T; Bruch HP; Duchrow M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):49-54. PubMed ID: 9498835
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
[TBL] [Abstract][Full Text] [Related]
9. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.
Maeda K; Chung YS; Takatsuka S; Ogawa Y; Sawada T; Yamashita Y; Onoda N; Kato Y; Nitta A; Arimoto Y
J Clin Oncol; 1995 Feb; 13(2):477-81. PubMed ID: 7531224
[TBL] [Abstract][Full Text] [Related]
11. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
[TBL] [Abstract][Full Text] [Related]
12. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
14. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
Oka K; Nakano T; Hoshi T
Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
[TBL] [Abstract][Full Text] [Related]
15. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of vascular density and cell proliferation in breast cancer patients.
Tynninen O; von Boguslawski K; Aronen HJ; Paavonen T
Pathol Res Pract; 1999; 195(1):31-7. PubMed ID: 10048092
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
[TBL] [Abstract][Full Text] [Related]
20. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
